Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency

Bridwell, 2019, Digoxin toxicity in a patient with pacemaker: a case report, Cureus, 11 Pincus, 2016, Management of digoxin toxicity, Aust Prescr, 39, 18, 10.18773/austprescr.2016.006 Haynes, 2008, Declining public health burden of digoxin toxicity from 1991 to 2004, Clin Pharmacol Ther, 84, 90, 10.1038/sj.clpt.6100458 Fenner, 2009, Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug, Clin Pharmacol Ther, 85, 173, 10.1038/clpt.2008.195 2010, Digoxin: serious drug interactions, Prescrire Int, 19, 68 Goldberger, 2012, Therapeutic ranges of serum digoxin concentrations in patients with heart failure, Am J Cardiol, 109, 1818, 10.1016/j.amjcard.2012.02.028 Lim, 2015, Clinical consequences of a miscalibrated digoxin immunoassay, Ther Drug Monit, 37, 104, 10.1097/FTD.0000000000000118 Tounsi, 2017, ABCB1 and SLCO1B3 gene polymorphisms and their impact on digoxin pharmacokinetics in atrial fibrillation patients among the Tunisian population, Pharmacology, 99, 250, 10.1159/000457906 Niemeijer, 2015, ABCB1 gene variants, digoxin and risk of sudden cardiac death in a general population, Heart, 101, 1973, 10.1136/heartjnl-2014-307419 Taghikhani, 2019, The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine, PLoS One, 14, 10.1371/journal.pone.0213747 Yamaguchi, 2010, Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1, Drug Metab Pharmacokinet, 25, 314, 10.2133/dmpk.25.314 Yukawa, 2001, Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model, Clin Pharmacokinet, 40, 773, 10.2165/00003088-200140100-00005 Komatsu, 2015, Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients, J Pharm Health Care Sci, 1, 25, 10.1186/s40780-015-0023-6 Jelliffe, 2014, A two-compartment population pharmacokinetic-pharmacodynamic model of digoxin in adults, with implications for dosage, Ther Drug Monit, 36, 387, 10.1097/FTD.0000000000000023 Li, 2015, Population pharmacokinetics of vancomycin in postoperative neurosurgical patients, J Pharm Sci, 104, 3960, 10.1002/jps.24604 Li, 2018, Factors influencing norvancomycin concentration in plasma and cerebrospinal fluid in patients after craniotomy and dosing guideline: a population approach, Clin Ther, 40, 74, 10.1016/j.clinthera.2017.11.005 Tsujimoto, 2008, Influence of SLCO1B3 gene polymorphism on the pharmacokinetics of digoxin in terminal renal failure, Drug Metab Pharmacokinet, 23, 406, 10.2133/dmpk.23.406 Toyohara, 2009, SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation, J Am Soc Nephrol, 20, 2546, 10.1681/ASN.2009070696 Suzuki, 2011, Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease, J Pharm Sci, 100, 3696, 10.1002/jps.22641 Keller, 1977, Bioavailability of digoxin: some pitfalls and problems, Int J Clin Pharmacol Biopharm, 15, 549 Zhou, 2010, Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice, Acta Pharmacol Sin, 31, 753, 10.1038/aps.2010.51 Moura, 2009, Drug-drug interactions associated with length of stay and cost of hospitalization, J Pharm Pharm Sci, 12, 266, 10.18433/J35C7Z Sharma, 2014, A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal, Indian J Pharmacol, 46, 152, 10.4103/0253-7613.129303 Welsh, 2014, Rapid detection of the active cardiac glycoside convallatoxin of lily of the valley using LOCI digoxin assay, Am J Clin Pathol, 142, 307, 10.1309/AJCPCOXF0O5XXTKD Chiang, 2020, Digoxin-amiodarone combination is associated with excess all-cause mortality in patients with atrial fibrillation, Sci Rep, 10, 4101, 10.1038/s41598-020-61065-4 Gurley, 2008, Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics, Mol Nutr Food Res, 52, 772, 10.1002/mnfr.200700081 Moj, 2017, Clarithromycin, midazolam, and digoxin: application of PBPK modeling to gain new insights into drug-drug interactions and co-medication regimens, AAPS J, 19, 298, 10.1208/s12248-016-0009-9 Hanke, 2018, PBPK models for CYP3A4 and P-gp DDI prediction: a modeling network of rifampicin, itraconazole, clarithromycin, midazolam, alfentanil, and digoxin, CPT Pharmacometrics Syst Pharmacol, 7, 647, 10.1002/psp4.12343 Eberl, 2007, Role of P-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies, Clin Pharmacokinet, 46, 1039, 10.2165/00003088-200746120-00004 Quinn, 2017, Macrolides, digoxin toxicity and the risk of sudden death: a population-based study, Drug Saf, 40, 835, 10.1007/s40264-017-0539-9 Alhadab, 2020, Semimechanistic modeling to guide venetoclax coadministration with ritonavir and digoxin, Clin Transl Sci, 10.1111/cts.12739 Yamazaki, 2019, Physiologically-based pharmacokinetic modeling approach to predict rifampin-mediated intestinal P-glycoprotein induction, CPT Pharmacometrics Syst Pharmacol, 8, 634, 10.1002/psp4.12458 Haas, 2007, Is this medicine really involved in a drug interaction?, South Med J, 100, 345, 10.1097/SMJ.0b013e3180381206 Vaidyanathan, 2008, Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren, J Clin Pharmacol, 48, 1323, 10.1177/0091270008323258 Abdel Jalil, 2020, A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population, Br J Clin Pharmacol, 10.1111/bcp.14272 Huidobro, 2018, Estimation of glomerular filtration rate with creatinine, Rev Med Chil, 146, 344 Morrison, 2010, Genetic variation in solute carrier genes is associated with preeclampsia, Am J Obstet Gynecol, 203, 10.1016/j.ajog.2010.06.004 Akiyama, 2013, Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3, PLoS One, 8, 10.1371/journal.pone.0066518